BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 19517692)

  • 21. Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia.
    Kwon JS; Elit L; Mazurka J; Moens F; Schmuck ML
    Gynecol Oncol; 2001 Aug; 82(2):367-70. PubMed ID: 11531296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
    Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for persistent gestational trophoblastic neoplasia.
    Kuyumcuoglu U; Guzel AI; Erdemoglu M; Celik Y
    J Exp Ther Oncol; 2011; 9(1):81-4. PubMed ID: 21275269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
    Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
    Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia.
    Chan KK; Huang Y; Tam KF; Tse KY; Ngan HY
    Am J Obstet Gynecol; 2006 Nov; 195(5):1282-6. PubMed ID: 16723109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inappropriate management of women with persistent low hCG results.
    Cole LA; Khanlian SA
    J Reprod Med; 2004 Jun; 49(6):423-32. PubMed ID: 15283048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pulmonary resection in the management of gestational trophoblastic neoplasia: a clinical study].
    Cao Y; Xiang Y; Feng FZ; Wan XR; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):928-30. PubMed ID: 19134333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastasis of gestational trophoblastic neoplasia to the spinal canal: a case report.
    Feng F; Xiang Y; Cao Y
    J Reprod Med; 2009 Sep; 54(9):576-8. PubMed ID: 19947036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
    Van Trommel NE; Sweep FC; Ross HA; Massuger LF; Thomas CM
    Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of treatment relating to gestational trophoblastic tumor registered to the French Trophoblastic Disease Reference Center (TDRC) in Lyon from 1999 to 2005].
    Golfier F; Labrousse C; Frappart L; Mathian B; Guastalla JP; Trillet-Lenoir V; Hajri T; Schott AM; Raudrant D
    Gynecol Obstet Fertil; 2007 Mar; 35(3):205-15. PubMed ID: 17336125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practical issues in the management of low-risk gestational trophoblast tumors.
    Savage P; Seckl M; Short D
    J Reprod Med; 2008 Oct; 53(10):774-80. PubMed ID: 19004403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The correlation of beta-subunit human chorionic gonadotropin level in the serum and first morning urine of patients with gestational trophoblastic disease.
    Benjapibal M; Wataganara T; Senawong S; Boriboonhirunsarn D; Suphanit I
    J Med Assoc Thai; 2001 Jul; 84(7):1000-5. PubMed ID: 11759958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting gestational trophoblastic neoplasia (GTN): is urine hCG the answer?
    Alazzam M; Young T; Coleman R; Hancock B; Drew D; Wilson P; Tidy J
    Gynecol Oncol; 2011 Sep; 122(3):595-9. PubMed ID: 21684585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human chorionic gonadotropin free beta-subunit measurement as a marker of placental site trophoblastic tumors.
    Harvey RA; Pursglove HD; Schmid P; Savage PM; Mitchell HD; Seckl MJ
    J Reprod Med; 2008 Aug; 53(8):643-8. PubMed ID: 18773632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum human chorionic gonadotropin regression pattern in persistent trophoblastic disease during chemotherapy.
    Lertkhachonsuk R; Limpongsanurak S
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S352-9. PubMed ID: 11529357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on the indication of surgical resection of pulmonary metastasis of malignant trophoblastic tumor].
    Zhang Y; Xiang Y; Ren T; Wan XR; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):83-6. PubMed ID: 15840284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
    Growdon WB; Wolfberg AJ; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
    J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.